175 related articles for article (PubMed ID: 4719545)
1. Fibrinolytic split products. A clinicopathological correlative study in adults with lupus glomerulonephritis and various renal diseases.
Bond RE; Donadio JV; Holley KE; Bowie EJ
Arch Intern Med; 1973 Aug; 132(2):182-7. PubMed ID: 4719545
[No Abstract] [Full Text] [Related]
2. Evaluation of patients with increased fibrinolytic split products (FSP) in their serum.
Cooper HA; Bowie EJ; Owen CA
Mayo Clin Proc; 1974 Sep; 49(9):654-7. PubMed ID: 4413314
[No Abstract] [Full Text] [Related]
3. What is the evidence for activated coagulation in glomerulonephritis?
Andrassy K; Ritz E; Mauerhoff T; Bommer J
Am J Nephrol; 1982; 2(6):293-300. PubMed ID: 6819778
[No Abstract] [Full Text] [Related]
4. A kinetic evaluation of hemostasis in renal disease.
George CR; Slichter SJ; Quadracci LJ; Striker GE; Harker LA
N Engl J Med; 1974 Nov; 291(21):1111-5. PubMed ID: 4608640
[No Abstract] [Full Text] [Related]
5. Split products of fibrin in human renal disease.
Stiehm ER; Trygstad CW
Am J Med; 1969 May; 46(5):774-86. PubMed ID: 4182522
[No Abstract] [Full Text] [Related]
6. Fibrin-fibrinogen degradation products in children with renal disease.
Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
[No Abstract] [Full Text] [Related]
7. [Lupus nephropathy. Hematic, tissue and urinary signs of coagulation involvement].
Stratta P; Canavese C; Dogliani M; Ragni R; Coppo R; Messina M; Rotunno M; Vercellone A
Minerva Nefrol; 1981; 28(3):215-20. PubMed ID: 7329597
[No Abstract] [Full Text] [Related]
8. Fibrin degradation products in renal diseases.
Kuroyanagi T; Kura K
Tohoku J Exp Med; 1976 Jul; 119(3):237-44. PubMed ID: 785695
[TBL] [Abstract][Full Text] [Related]
9. The role of coagulation in renal disease.
MacDonald MK; Clarkson AR; Davison AM
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):809-28. PubMed ID: 4807810
[No Abstract] [Full Text] [Related]
10. [Fibrinogen-fibrin degradation products in glomerular diseases].
Sasdelli M; Fabbri L; Cagnoli L; Zuccalà A
Minerva Nefrol; 1973; 20(3):170-6. PubMed ID: 4761428
[No Abstract] [Full Text] [Related]
11. Pathophysiological response of the blood coagulation system in acute glomerulonephritis.
Alkjaersig NK; Fletcher AP; Lewis ML; Cole BR; Ingelfinger JR; Robson AM
Kidney Int; 1976 Oct; 10(4):319-28. PubMed ID: 994377
[TBL] [Abstract][Full Text] [Related]
12. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
[No Abstract] [Full Text] [Related]
13. [Study of several parameters of hemostasis in Masugi's rabbit nephritis].
Lagrue G; Levent M; Gouault-Heilmann M; Hirbec G; Branellec A
Pathol Biol (Paris); 1975 Feb; 23(2):139-44. PubMed ID: 1093104
[TBL] [Abstract][Full Text] [Related]
14. Exploration of intraglomerular phenomena by measurement of the level of fibrin degradation products in the renal vein blood.
Conte J; Boneu B; Mignon-Conte ; Suc JM
Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):915-26. PubMed ID: 4807811
[No Abstract] [Full Text] [Related]
15. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
Zorina SS; Krasik IaD
Ter Arkh; 1974; 46(7):54-62. PubMed ID: 4408677
[No Abstract] [Full Text] [Related]
16. [Case of systemic lupus erythematosus associated with disseminated intravascular coagulation (DIC); with special reference to the relation between autoimmune phenomena and coagulation-fibrinolysis reactions].
Shinmyozu K; Ichinose A; Okada A; Maruyama I; Igata A
Nihon Naika Gakkai Zasshi; 1983 Jul; 72(7):947-54. PubMed ID: 6663182
[No Abstract] [Full Text] [Related]
17. Complement and coagulation in Rocky Mountain spotted fever.
Graybill JR; Hawiger J; Des Prez RM
South Med J; 1973 Apr; 66(4):410-3. PubMed ID: 4708236
[No Abstract] [Full Text] [Related]
18. Effect of surgical operations on certain tests used to diagnose intravascular coagulation and fibrinolysis.
Egan EL; Bowie EJ; Kazmier FJ; Gilchrist GS; Woods JW; Owen CA
Mayo Clin Proc; 1974 Sep; 49(9):658-64. PubMed ID: 4413095
[No Abstract] [Full Text] [Related]
19. Coagulation abnormalities in patients with inoperable lung cancer.
Hagedorn AB; Bowie EJ; Elveback LR; Owen CA
Mayo Clin Proc; 1974 Sep; 49(9):647-53. PubMed ID: 4278033
[No Abstract] [Full Text] [Related]
20. Fibrinogen degradation products in serum and urine of patients with systemic lupus erythematosus. Relation to renal disease and pathogenetic mechanism.
Kanyerezi BR; Lwanga SK; Block KJ
Arthritis Rheum; 1971; 14(2):267-75. PubMed ID: 5549972
[No Abstract] [Full Text] [Related]
[Next] [New Search]
